Cardiology Medical News about antiplatelet and coagulation therapies

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Combining antiplatelet and anticoagulant therapies
JACC - Journal of the American College of Cardiology, 07/02/09

Holmes DR et al. – A JACC white paper reports that it is both prudent and timely to review treatment strategies using combinations of antiplatelet and anticoagulant therapies as well as strategies aimed at reducing bleeding risk in pts treated with these therapies.

Methods

Review focusing on combining antiplatelet and anticoagulant therapies

Results

Antiplatelet therapy: cornerstone for both primary and secondary prevention therapies for ischemic events resulting from coronary atherosclerotic disease
Dual antiplatelet therapy (aspirin + a thienopyridine, usually clopidogrel): central role in treatment of acute coronary syndromes and after coronary stent deployment
In addition to antiplatelet therapy, anticoagulant therapy may be indicated for stroke prevention for atrial fibrillation, profound left ventricular dysfunction, and after mechanical prosthetic heart valve replacement
Use of triple antithrombotic therapy (dual antiplatelet regimen + warfarin) may increase due to an aging pt population
Triple therapy: may prevent both thromboembolism and stent thrombosis; associated with significant bleeding hazards

<< Previous
Elevated depression symptoms predict long-term cardiovascular...

Next >>
Insulin resistance and endothelial dysfunction: Are...